Evofem Biosciences, Inc.
12400 High Bluff Drive Suite 600,
San Diego, 92130, CA,
United States
San Diego, 92130, CA,
United States
1 858-550-1900
Life Sciences
Evofem Biosciences, Inc. Technographics
Evofem Biosciences, Inc. Technographics, Software Purchases, AI and Digital Transformation Initiatives
Discover the latest software purchases and digital transformation initiatives being undertaken by Evofem Biosciences, Inc. and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 119 Evofem Biosciences, Inc. employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that Evofem Biosciences, Inc. has purchased the following applications: Microsoft 365 for Collaboration in 2015, DocuSign eSignature for Digital Signing in 2022, Veeva CRM for CRM in 2021 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems Evofem Biosciences, Inc. is running and its propensity to invest more and deepen its relationship with Microsoft , EQS Group , DocuSign or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing Evofem Biosciences, Inc. revenues, which have grown to $8.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Evofem Biosciences, Inc. intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
Evofem Biosciences, Inc. Tech Stack and Enterprise Applications
Collaboration
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Microsoft | Legacy | Microsoft 365 | Collaboration | Collaboration | n/a | 2015 | 2015 |
In 2015 Evofem Biosciences, Inc. deployed Microsoft 365 as its Collaboration platform. The Microsoft 365 deployment is implemented as a cloud hosted tenant and is referenced on the company website for content and communication workflows. The implementation supports core corporate collaboration across research, corporate and commercial functions.
The environment leverages Microsoft 365 capabilities such as Exchange Online for enterprise email, SharePoint Online for document management and intranet content, and Microsoft Teams for meetings and real time collaboration. Identity and access are administered at the tenant level using Azure Active Directory, with centralized administration, user provisioning and permission structures to manage internal and external collaboration. Governance focuses on tenant level policies and content controls to align collaboration workflows with regulatory and corporate requirements.
|
|
|
|
|
Event Management | Collaboration |
|
2022 | 2022 |
|
Content Management
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| DocuSign | Legacy | DocuSign eSignature | Digital Signing | Content Management | n/a | 2022 | 2022 |
In 2022, Evofem Biosciences, Inc. deployed DocuSign eSignature as a Digital Signing solution. The implementation places DocuSign eSignature on the company website to capture legally binding electronic signatures for public-facing forms and customer-facing signing workflows.
The deployment is delivered as a web-embedded digital signature layer, using browser-based signing flows, envelope routing, and authentication controls typical of Digital Signing implementations. Configuration focused on document presentation, signature capture, and automated delivery notifications to signers, with the DocuSign eSignature instance operating alongside Evofem Biosciences, Inc. website workflows to centralize online signature capture for external interactions.
|
CRM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Veeva Systems | Legacy | Veeva CRM | CRM | CRM | n/a | 2021 | 2021 |
In 2021, Evofem Biosciences, Inc. deployed Veeva CRM to support its women's health commercial operations for Phexxi. Veeva CRM is used as a CRM to capture pre-call planning, call continuum activities, and detailed field notes by sales representatives covering Denver CO, Colorado Springs, Pueblo CO, Boulder CO, Fort Collins CO and Laramie WY.
Configuration emphasis included call planning, territory routing, activity capture, and closed loop marketing content management that enforced use of company approved materials such as core visual aids, peer connect videos, iPad clinical media tools, case-study handouts and patient access card inventories. The Veeva CRM deployment also supported tracking of account reach objectives, sample management workflows, and scheduling of medical science liaison meetings as part of account engagement processes.
Operational coverage centered on field sales and commercial operations, with workflow interchanges with medical affairs for speaker programs and reimbursement support activities such as prior authorizations, step therapy and coverage appeals. Field users recorded activity data in Veeva CRM and in some instances in Salesforce, while adherence to compliance wire training and corporate AMEX expense controls governed usage and content distribution.
Sales outcomes documented during the Veeva CRM usage window include representative rankings and attainment where a representative finished Q4 2021 ranked second at 172 percent of goal, Q3 2021 ranked fifth at 130 percent of goal, and Q1 2022 ranked sixth among 59 reps. Governance relied on approved content and routing adjustments driven by prescribing trends to maintain a 90 percent target reach of assigned accounts.
|
|
|
|
|
Sales Automation, CRM, Sales Engagement | CRM |
|
2022 | 2022 |
|
ITSM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
IT Service Management | ITSM |
|
2020 | 2020 |
|
IaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2013 | 2013 |
|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2014 | 2014 |
|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2021 | 2021 |
|
IT Decision Makers and Key Stakeholders at Evofem Biosciences, Inc.
| First Name | Last Name | Title | Function | Department | Phone | |
|---|---|---|---|---|---|---|
| No data found | ||||||
Apps Being Evaluated by Evofem Biosciences, Inc. Executives
APPS RUN THE WORLD tracks software evaluation trends across 2 million companies worldwide, including buyer insights from Evofem Biosciences, Inc. IT executives and key decision makers. As part of ARTW Buyer Intent and technographics insights, these findings provide useful visibility into the Evofem Biosciences, Inc. digital transformation priorities and AI adoption trends.
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||
FAQ - APPS RUN THE WORLD Evofem Biosciences, Inc. Technographics
Evofem Biosciences, Inc. is a Life Sciences organization based in United States,
with around 119 employees and annual revenues of $8.0 million.
Evofem Biosciences, Inc. operates a diverse technology stack with applications such as
Microsoft 365, DocuSign eSignature and Veeva CRM,
covering areas like Collaboration, Digital Signing and CRM.
Evofem Biosciences, Inc. has invested in cloud applications and AI-driven platforms to optimize efficiency and growth,
collaborating with vendors such as Microsoft, DocuSign and Veeva Systems.
Evofem Biosciences, Inc. recently adopted applications including
EQS Audio and Video Webcast in 2022, DocuSign eSignature in 2022 and Salesforce Sales Cloud in 2022,
highlighting its ongoing modernization strategy.
APPS RUN THE WORLD maintains an up-to-date database of Evofem Biosciences, Inc.’s key decision makers and IT executives,
available to Premium subscribers.
Our research team continuously updates Evofem Biosciences, Inc.’s profile with verified software purchases,
vendor relationships, and digital initiatives identified from public and proprietary sources.
Subscribe to APPS RUN THE WORLD to access the complete Evofem Biosciences, Inc. technographics profile,
including detailed breakdowns by category, vendor, and IT decision makers.